On Monday, January 29, Crowell & Moring announced the addition of Dr. Brian Paul Gearing, as a partner in the firm’s Intellectual Property Group in New York. With more than a decade of experience in patent portfolio management and all stages of IP litigation.
“Brian’s impressive technical background and extensive practice experience provide a terrific complement to our IP Group and will benefit clients who are navigating IP litigation issues,” said Philip T. Inglima, chair of Crowell & Moring. “He will be a valuable asset as we build upon our presence and full-service IP capabilities in New York.”
Dr. Gearing has been trial counsel on numerous high-profile litigations that have resulted in favorable judgments and settlements for his clients, which have included several multinational technology conglomerates, a leading Japanese pharmaceutical company, an international electronics and smart appliance technology company, national retailers, and other leading-edge companies.
Potential developments regarding inter partes reviews, legislation affecting non-practicing entities and their ability to assert patent rights, antitrust claims arising from the enforcement of standard-essential patents, RICO claims in the context of IP litigation, as well as venue issues regarding patent cases, are all subjects that Dr. Gearing closely monitors for his clients.
Full Content: PR Newswire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas